Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

CareRelax ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.3% 2.3%   Bankruptcy risk   3.1% 2.0% 1.6% 1.0% 3.1% 1.2% 9.7% 9.7%   Credit score (0-100)   58 70 75 85 56 81 26 26   Credit rating   BBB A A A BBB A BB BB   Credit limit (kDKK)   0.0 0.1 5.4 125.6 0.0 88.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   791 639 1,359 1,640 529 1,459 0.0 0.0   EBITDA   487 201 991 1,020 49.3 967 0.0 0.0   EBIT   487 201 991 1,020 49.3 967 0.0 0.0   Pre-tax profit (PTP)   462.5 180.1 972.3 1,008.4 26.2 958.0 0.0 0.0   Net earnings   360.2 140.1 758.1 786.0 19.8 746.4 0.0 0.0   Pre-tax profit without non-rec. items   463 180 972 1,008 26.2 958 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   84.4 244 320 361 112 59.4 0.0 0.0   Shareholders equity total   579 719 1,277 1,563 1,583 2,329 1,579 1,579   Interest-bearing liabilities   111 474 0.0 222 111 503 0.0 0.0   Balance sheet total (assets)   1,268 1,509 2,622 2,564 2,001 3,443 1,579 1,579   Net Debt   -9.4 474 -452 208 82.9 503 -1,579 -1,579     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   791 639 1,359 1,640 529 1,459 0.0 0.0   Gross profit growth   123.0% -19.1% 112.6% 20.7% -67.8% 176.1% -100.0% 0.0%   Employees   0 0 0 0 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,268 1,509 2,622 2,564 2,001 3,443 1,579 1,579   Balance sheet change%   -8.7% 19.0% 73.8% -2.2% -21.9% 72.0% -54.1% 0.0%   Added value   487.3 201.3 991.1 1,020.1 49.3 966.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -99 160 76 41 -249 -53 -59 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   61.6% 31.5% 72.9% 62.2% 9.3% 66.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   36.7% 14.5% 48.1% 39.5% 2.2% 36.0% 0.0% 0.0%   ROI %   69.3% 21.3% 79.6% 66.6% 2.8% 43.3% 0.0% 0.0%   ROE %   90.3% 21.6% 76.0% 55.3% 1.3% 38.2% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   45.7% 47.7% 48.7% 61.0% 80.8% 68.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -1.9% 235.4% -45.6% 20.4% 168.2% 52.1% 0.0% 0.0%   Gearing %   19.1% 65.9% 0.0% 14.2% 7.0% 21.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   8.1% 7.3% 9.1% 15.2% 13.9% 6.8% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.5 0.2 0.8 0.3 0.9 1.0 0.0 0.0   Current Ratio   1.7 1.6 1.7 2.2 4.5 3.0 0.0 0.0   Cash and cash equivalent   120.2 0.0 451.6 13.8 28.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   494.5 485.0 973.3 1,203.2 1,470.7 2,270.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 49 967 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 49 967 0 0   EBIT / employee   0 0 0 0 49 967 0 0   Net earnings / employee   0 0 0 0 20 746 0 0